{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:52:12Z","timestamp":1793796732019,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["ANRS 12381"],"award-info":[{"award-number":["ANRS 12381"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pre-exposure prophylaxis (PrEP) is recommended by the WHO for HIV prevention among female sex workers (FSWs). A study conducted in 2016\u20132017 in C\u00f4te d\u2019Ivoire showed that if PrEP is acceptable, FSWs also have many uncovered sexual health needs. Based on this evidence, the ANRS 12381 PRINCESSE project was developed in collaboration with a community-based organization. The main objective is to develop, document, and analyze a comprehensive sexual and reproductive healthcare package among FSWs in C\u00f4te d\u2019Ivoire.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PRINCESSE is an open, single-arm interventional cohort of 500 FSWs in San Pedro (C\u00f4te d\u2019Ivoire) and its surroundings. Recruitment started on November 26th, 2019 and is ongoing; the cohort is planned to last at least 30\u2009months. The healthcare package (including HIV, hepatitis B, and sexually transmitted infection management, pregnancy screening, and contraception) is available both at mobile clinics organized for a quarterly follow-up (10 intervention sites, each site being visited every two weeks) and at a fixed clinic.<\/jats:p>\n                <jats:p>Four waves of data collection were implemented: (i) clinical and safety data; (ii) socio-behavioral questionnaires; (iii) biological data; and (iv) in-depth interviews with female participants. Four additional waves of data collection are scheduled outside the cohort itself: (i) the medical and activity records of Aprosam for the PRINCESSE participants; (ii) the medical records of HIV+ FSW patients not participating in the PRINCESSE cohort, and routinely examined by Aprosam; (iii) in-depth interviews with key informants in the FSW community; and (iv) in-depth interviews with PRINCESSE follow-up actors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The PRINCESSE project is one of the first interventions offering HIV oral PrEP as part of a more global sexual healthcare package targeting both HIV- and HIV+ women. Second, STIs and viral hepatitis B care were offered to all participants, regardless of their willingness to use PrEP. Another innovation is the implementation of mobile clinics for chronic\/quarterly care. In terms of research, PRINCESSE is a comprehensive, interdisciplinary project combining clinical, biological, epidemiological, and social specific objectives and outcomes to document the operational challenges of a multidisease program in real-life conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The PRINCESSE project was registered on the Clinicaltrial.gov website (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03985085?term=NCT03985085&amp;draw=2&amp;rank=1\">NCT03985085<\/jats:ext-link>) on June 13, 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-12235-0","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T12:02:59Z","timestamp":1638619379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A community-based healthcare package combining testing and prevention tools, including pre-exposure prophylaxis (PrEP), immediate HIV treatment, management of hepatitis B virus, and sexual and reproductive health (SRH), targeting female sex workers (FSWs) in C\u00f4te d\u2019Ivoire: the ANRS 12381 PRINCESSE project"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3599-5445","authenticated-orcid":false,"given":"Valentine","family":"Becquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2312-8886","authenticated-orcid":false,"given":"Marcellin","family":"Nouaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8971-6878","authenticated-orcid":false,"given":"M\u00e9lanie","family":"Plazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Agoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mence","family":"Z\u00e9bago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Montoyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1952-6729","authenticated-orcid":false,"given":"Aude","family":"Jary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Coffie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7690-4856","authenticated-orcid":false,"given":"Serge","family":"Eholi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7097-700X","authenticated-orcid":false,"given":"Joseph","family":"Larmarange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the ANRS 12381 PRINCESSE team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"12235_CR1","unstructured":"UNAIDS. UNAIDS Data 2020 [Internet]. Geneva: UNAIDS; 2020 [cit\u00e9 16 juill 2021]. 436 p. Disponible sur: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2020_aids-data-book_en.pdf"},{"key":"12235_CR2","unstructured":"Bamba A, Grover E, Ezouatchi R, Thiam-Niangoin M, Papworth E, Grosso A, et al. \u00c9tude biologique et comportementale des IST\/VIH\/sida chez les professionnelles du sexe du District d\u2019Abidjan et examen des interventions en direction des populations cl\u00e9s en C\u00f4te d\u2019Ivoire. Abidjan: Minist\u00e8re de la Sant\u00e9 et de la Lutte contre le Sida, Enda Sant\u00e9, Johns Hopkins University; 2014 nov p. 100."},{"key":"12235_CR3","unstructured":"Nouaman MN, Becquet V, Masumbuko J-M, Anoma C, Soh K, Plazy M, et al. \u00c9valuation de l\u2019incidence du VIH chez des travailleuses du sexe en C\u00f4te d\u2019Ivoire (PrEP-CI ANRS 12361). In AFRAVIH Bordeaux; 2018."},{"key":"12235_CR4","unstructured":"UNAIDS. AIDS info - C\u00f4te d\u2019Ivoire [Internet]. 2019 [cit\u00e9 22 juin 2022]. Disponible sur: https:\/\/aidsinfo.unaids.org\/"},{"issue":"1","key":"12235_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028508","volume":"10","author":"V Becquet","year":"2020","unstructured":"Becquet V, Nouaman M, Plazy M, Masumbuko J-M, Anoma C, Kouame S, et al. Sexual health needs of female sex workers in C\u00f4te d\u2019Ivoire: a mixed-methods study to prepare the future implementation of pre-exposure prophylaxis (PrEP) for HIV prevention. BMJ Open. 2020;10(1):e028508.","journal-title":"BMJ Open"},{"issue":"9962","key":"12235_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(14)60931-4","volume":"385","author":"K Shannon","year":"2015","unstructured":"Shannon K, Strathdee SA, Goldenberg SM, Duff P, Mwangi P, Rusakova M, et al. Global epidemiology of HIV among female sex workers: influence of structural determinants. Lancet. 2015;385(9962):55\u201371.","journal-title":"Lancet"},{"key":"12235_CR7","doi-asserted-by":"publisher","unstructured":"Ghimire L, Smith WCS, van Teijlingen ER, Dahal R, Luitel NP. Reasons for non- use of condoms and self- efficacy among female sex workers: a qualitative study in Nepal. BMC Womens Health. 2011;11(42). https:\/\/doi.org\/10.1186\/1472-6874-11-42.","DOI":"10.1186\/1472-6874-11-42"},{"issue":"1","key":"12235_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6874-12-13","volume":"12","author":"R Lotfi","year":"2012","unstructured":"Lotfi R, Tehrani FR, Yaghmaei F, Hajizadeh E. Barriers to condom use among women at risk of HIV\/AIDS: a qualitative study from Iran. BMC Womens Health. 2012;12(1):13.","journal-title":"BMC Womens Health"},{"issue":"9","key":"12235_CR9","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1080\/09540121.2018.1563284","volume":"31","author":"G George","year":"2019","unstructured":"George G, Nene S, Beckett S, Durevall D, Lindskog A, Govender K. Greater risk for more money: the economics of negotiating condom use amongst sex workers in South Africa. AIDS Care. 2019;31(9):1168\u201371.","journal-title":"AIDS Care"},{"key":"12235_CR10","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1097\/QAI.0000000000000451","volume":"68","author":"AL Wirtz","year":"2015","unstructured":"Wirtz AL, Schwartz S, Ketende S, Anato S, Nadedjo FD, Ouedraogo HG, et al. Sexual violence, condom negotiation, and condom use in the context of sex work: results from two west African countries. JAIDS J Acquir Immune Defic Syndr. 2015;68:S171.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"3","key":"12235_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1136\/sti.2009.037846","volume":"86","author":"MR Decker","year":"2010","unstructured":"Decker MR, McCauley HL, Phuengsamran D, Janyam S, Seage GR, Silverman JG. Violence victimisation, sexual risk and sexually transmitted infection symptoms among female sex workers in Thailand. Sex Transm Infect. 2010;86(3):236\u201340.","journal-title":"Sex Transm Infect"},{"key":"12235_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2147\/IJWH.S260481","volume":"12","author":"MA Mohammadi Gharehghani","year":"2020","unstructured":"Mohammadi Gharehghani MA, Khosravi B, Irandoost SF, Soofizad G, Yoosefi Lebni J. Barriers to Condom Use Among Female Sex Workers in Tehran, Iran: A Qualitative Study. Int J Womens Health. 2020;12:681\u20139.","journal-title":"Int J Womens Health"},{"key":"12235_CR13","unstructured":"World Health Organization. Consolidated Guidelines on Hiv Prevention, Diagnosis, Treatment and Care for Key Populations [Internet]. World Health Organization; 2016 [cit\u00e9 26 sept 2019]. http:\/\/proxy.library.carleton.ca\/loginurl=, https:\/\/www.deslibris.ca\/ID\/10063272."},{"issue":"5","key":"12235_CR14","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"key":"12235_CR15","unstructured":"Molina J-M, Capitant C, Spire B, Pialoux G, Chidiac C, Charreau I, et al. On demand PrEP with Oral TDF\/FTC in MSM results of the ANRS Ipergay trial. Seattle; 2015."},{"key":"12235_CR16","doi-asserted-by":"crossref","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet Lond Engl. 2015.","DOI":"10.1016\/S0140-6736(15)00056-2"},{"key":"12235_CR17","unstructured":"World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV [Internet]. 2015 [cit\u00e9 22 juin 2021]. Disponible sur: https:\/\/www.who.int\/publications\/i\/item\/9789241509565"},{"issue":"3","key":"12235_CR18","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","volume":"66","author":"AL Corneli","year":"2014","unstructured":"Corneli AL, Deese J, Wang M, Taylor D, Ahmed K, Agot K, et al. FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis. J Acquir Immune Defic Syndr 1999. 2014;66(3):324\u201331.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"6","key":"12235_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"11","key":"12235_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25208","volume":"21","author":"A Mboup","year":"2018","unstructured":"Mboup A, B\u00e9hanzin L, Gu\u00e9dou FA, Geraldo N, Goma-Mats\u00e9ts\u00e9 E, Gigu\u00e8re K, et al. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study. J Int AIDS Soc. 2018;21(11):e25208.","journal-title":"J Int AIDS Soc"},{"issue":"11","key":"12235_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pmed.1002444","volume":"14","author":"R Eakle","year":"2017","unstructured":"Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):1\u201317.","journal-title":"PLoS Med"},{"key":"12235_CR22","doi-asserted-by":"crossref","unstructured":"Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):e25081.","DOI":"10.1002\/jia2.25081"},{"issue":"6","key":"12235_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/QAD.0000000000001749","volume":"32","author":"J Larmarange","year":"2018","unstructured":"Larmarange J, Becquet V, Masumbuko J-M, Nouaman M, Plazy M, Danel C, et al. Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B. AIDS. 2018;32(6):829\u201330.","journal-title":"AIDS"},{"issue":"4","key":"12235_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/sti.2002.004077","volume":"81","author":"S Mullick","year":"2005","unstructured":"Mullick S. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005;81(4):294\u2013302.","journal-title":"Sex Transm Infect"},{"issue":"Supplement 3","key":"12235_CR25","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1097\/QAI.0000000000000448","volume":"68","author":"S Schwartz","year":"2015","unstructured":"Schwartz S, Papworth E, Thiam-Niangoin M, Abo K, Drame F, Diouf D, et al. An urgent need for integration of family planning services into HIV care: the high burden of unplanned pregnancy, termination of pregnancy, and limited contraception use among female sex workers in C\u00f4te d\u2019Ivoire. JAIDS J Acquir Immune Defic Syndr. 2015;68(Supplement 3):S91\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"5","key":"12235_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1136\/sti.2008.035543","volume":"85","author":"K Baisley","year":"2009","unstructured":"Baisley K, Changalucha J, Weiss HA, Mugeye K, Everett D, Hambleton I, et al. Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors. Sex Transm Infect. 2009;85(5):370\u20135.","journal-title":"Sex Transm Infect"},{"issue":"4","key":"12235_CR27","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10995-011-0798-5","volume":"16","author":"R Garg","year":"2012","unstructured":"Garg R, Goyal S, Gupta S. India moves towards menstrual hygiene: subsidized sanitary napkins for rural adolescent girls\u2014issues and challenges. Matern Child Health J. 2012;16(4):767\u201374.","journal-title":"Matern Child Health J"},{"key":"12235_CR28","unstructured":"Morlat P, Groupe des experts \u201c\u00a0Prise en charge m\u00e9dicale des personnes infect\u00e9es par le VIH\u00a0\u201d. Prise en charge m\u00e9dicale des personnes vivant avec le VIH\u00a0: Recommandations du groupe d\u2019experts, Actualisation 2015, Prophylaxie Pr\u00e9-Exposition [Internet]. Paris: CNS, ANRS; 2015 p. 18. Disponible sur: http:\/\/www.cns.sante.fr\/IMG\/pdf\/experts-vih_prep2015.pdf"},{"issue":"10003","key":"12235_CR29","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0140-6736(15)61412-X","volume":"386","author":"A Schweitzer","year":"2015","unstructured":"Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546\u201355.","journal-title":"Lancet"},{"issue":"4","key":"12235_CR30","doi-asserted-by":"publisher","first-page":"ofy060","DOI":"10.1093\/ofid\/ofy060","volume":"5","author":"B Seri","year":"2018","unstructured":"Seri B, Minga A, Gabillard D, Dembele B, Konate S, Le Carrou J, et al. Twenty-Year Evolution of Hepatitis B Virus and Human Immunodeficiency Virus Prevalence and Incidence in Voluntary Blood Donors in C\u00f4te d\u2019Ivoire. Open Forum Infect Dis. 2018;5(4):ofy060.","journal-title":"Open Forum Infect Dis"},{"key":"12235_CR31","unstructured":"Nouaman M, Jacquet A, Tanon A, Coffie PA, Ekou\u00e9vi DK, Anoma C, et al. Infection \u00e0 VIH et fibrose h\u00e9patique chez des travailleuses du sexe et des hommes ayant des rapports sexuels avec d\u2019autres hommes \u00e0 Abidjan, C\u00f4te d\u2019Ivoire. In AFRAVIH Bruxelles; 2016. Disponible sur: http:\/\/www.afravih2016.org\/images\/Programme\/Livre_des_resumes_CO.pdf."},{"issue":"2","key":"12235_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/sifp.12020","volume":"48","author":"NB Ippoliti","year":"2017","unstructured":"Ippoliti NB, Nanda G, Wilcher R. Meeting the reproductive health needs of female key populations affected by HIV in low-and middle-income countries: a review of the evidence. Stud Fam Plan. 2017;48(2):121\u201351.","journal-title":"Stud Fam Plan"},{"key":"12235_CR33","doi-asserted-by":"crossref","unstructured":"Wahed T, Alam A, Sultana S, Rahman M, Alam N, Martens M, et al. Barriers to sexual and reproductive healthcare services as experienced by female sex workers and service providers in Dhaka city, Bangladesh. PLoS ONE. 2017;12(7):e0182249.","DOI":"10.1371\/journal.pone.0182249"},{"issue":"3","key":"12235_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1080\/14681994.2019.1574970","volume":"34","author":"DA Sawicki","year":"2019","unstructured":"Sawicki DA, Meffert BN, Read K, Heinz AJ. Culturally competent health care for sex workers: an examination of myths that stigmatize sex work and hinder access to care. Sex Relatsh Ther. 2019;34(3):355\u201371.","journal-title":"Sex Relatsh Ther"},{"issue":"7","key":"12235_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/09540120500099936","volume":"17","author":"BE Thomas","year":"2005","unstructured":"Thomas BE, Rehman F, Suryanarayanan D, Josephine K, Dilip M, Dorairaj VS, et al. How stigmatizing is Stigma in the life of people living with HIV: A study on HIV positive individuals from Chennai, South India. AIDS Care. 2005;17(7):795\u2013801.","journal-title":"AIDS Care"},{"issue":"1","key":"12235_CR36","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1186\/1471-2458-14-1246","volume":"14","author":"M Beaulieu","year":"2014","unstructured":"Beaulieu M, Adrien A, Potvin L, Dassa C. Comit\u00e9 consultatif sur les attitudes envers les PVVIH. Stigmatizing attitudes towards people living with HIV\/AIDS: validation of a measurement scale. BMC Public Health. 2014;14(1):1246.","journal-title":"BMC Public Health"},{"issue":"1","key":"12235_CR37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12913-017-2068-8","volume":"17","author":"S Vorasane","year":"2017","unstructured":"Vorasane S, Jimba M, Kikuchi K, Yasuoka J, Nanishi K, Durham J, et al. An investigation of stigmatizing attitudes towards people living with HIV\/AIDS by doctors and nurses in Vientiane, Lao PDR. BMC Health Serv Res. 2017;17(1):125.","journal-title":"BMC Health Serv Res"},{"key":"12235_CR38","unstructured":"Sika LG, Kacou \u00c9A, Ali-Kouadio A, Appiah A. Analyses des connaissances, attitudes et pratiques des professionnel(le)s du sexe dans dix-huit villes de C\u00f4te d\u2019Ivoire. Abidjan: Minist\u00e8re de la Sant\u00e9 et de la Lutte contre le Sida de C\u00f4te d\u2019Ivoire, PLS-PHV, PUMLS, Banque Mondiale, ENSEA; 2012 avr p. 241."},{"key":"12235_CR39","unstructured":"WHO. Guidelines for the Prevention, Care and Treatment of Persons with chronic Hepatitis B Infection. Geneva: World Health Organisation; 2015 mars p. 166."},{"key":"12235_CR40","unstructured":"PNLS. Directives 2015 de prise en charge des personnes vivant avec le VIH en C\u00f4te d\u2019Ivoire. Abidjan: Programme National de Lutte contre le Sida; 2015 p. 32."},{"key":"12235_CR41","unstructured":"WHO. WHO Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 1: Clinical. Geneva: World Health Organisation; 2017 p. 28. Report No.: WHO\/HIV\/2017.17."},{"key":"12235_CR42","doi-asserted-by":"crossref","unstructured":"Mboup A, B\u00e9hanzin L, Gu\u00e9dou F, Gigu\u00e8re K, Geraldo N, Zannou DM, et al. Comparison of adherence measurement tools used in a pre-exposure prophylaxis demonstration study among female sex workers in Benin. Medicine (Baltimore). 2020;99(21) Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7249870\/. [cit\u00e9 19 mai 2021].","DOI":"10.1097\/MD.0000000000020063"},{"key":"12235_CR43","unstructured":"Mboup A, Diabat\u00e9 S, B\u00e9hanzin L, Gu\u00e9dou FA, Zannou DM, K\u00eak\u00ea RK, et al. Determinants of HIV pre-exposure prophylaxis (PrEP) adherence among female sex workers in a demonstration study in Cotonou, Benin: a study of behavioral and demographic factors. Sex Transm Dis [Internet]. 23 avr 2021 [cit\u00e9 27 avr 2021];publish ahead of print. Disponible sur: https:\/\/journals.lww.com\/stdjournal\/Abstract\/9000\/Determinants_of_HIV_pre_exposure_prophylaxis.97774.aspx"},{"issue":"1","key":"12235_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/QAI.0000000000001980","volume":"81","author":"E Fearon","year":"2019","unstructured":"Fearon E, Phillips A, Mtetwa S, Chabata ST, Mushati P, Cambiano V, et al. How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis. J Acquir Immune Defic Syndr 1999. 2019;81(1):24\u201335.","journal-title":"J Acquir Immune Defic Syndr 1999"},{"issue":"8","key":"12235_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25588","volume":"23","author":"J Kagaayi","year":"2020","unstructured":"Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Str\u00f6mdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in south-Central Uganda. J Int AIDS Soc. 2020;23(8):e25588.","journal-title":"J Int AIDS Soc"},{"key":"12235_CR46","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1097\/QAI.0000000000000442","volume":"68","author":"B Vuylsteke","year":"2015","unstructured":"Vuylsteke B, Semd\u00e9 G, Auld AF, Sabatier J, Kouakou J, Etti\u00e8gne-Traor\u00e9 V, et al. Retention and risk factors for loss to follow-up of female and male sex workers on antiretroviral treatment in Ivory Coast: a retrospective cohort analysis. JAIDS J Acquir Immune Defic Syndr. 2015;68:S99\u2013106.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"11","key":"12235_CR47","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1177\/0956462420943704","volume":"31","author":"M Sarr","year":"2020","unstructured":"Sarr M, Gueye D, Mboup A, Diouf O, Bao MDB, Ndiaye AJ, et al. Uptake, retention, and outcomes in a demonstration project of pre-exposure prophylaxis among female sex workers in public health centers in Senegal. Int J STD AIDS. 2020;31(11):1063\u201372.","journal-title":"Int J STD AIDS"},{"issue":"S1","key":"12235_CR48","first-page":"10","volume":"24","author":"MK Brook","year":"2021","unstructured":"Brook MK, Ismail A, Magni S, Fellows T, Katahoire AR, Ayebare F, et al. User assessment of a microarray patch for HIV PrEP and as a multipurpose prevention technology for HIV and pregnancy prevention: perspectives from Uganda and South Africa. J Int AIDS Soc. 2021;24(S1):10\u20132.","journal-title":"J Int AIDS Soc"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-12235-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-12235-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T04:30:01Z","timestamp":1638765001000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-12235-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["12235"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-12235-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The PRINCESSE protocol version 1.0 was submitted in November 2018 to the <i>Comit\u00e9 National d\u2019Ethique des Sciences de la vie et de la sant\u00e9 de la C\u00f4te d\u2019Ivoire<\/i> (CNESVS). The second version, including changes requested by CNESVS, was reviewed and approved on March 4th, 2019 (ref: 152\u201318\/MSHP\/CNESVS-km). The third version, introducing in-depth interviews by phone, was approved on March 15th, 2021. The fourth version, adding a biological component (specific objective 7), was approved on May 18th, 2021. These ethics approvals cover all study sites.The PRINCESSE project is registered on the Clinicaltrial.gov website (NCT03985085).Several consent forms are collected for the PRINCESSE study:","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2214"}}